1. The impact of SARS-CoV-2 pandemic on Oncologic and Degenerative Spine Surgery Department activity: the experience of Rizzoli Orthopaedic Institute under COVID-19 lockdown.
- Author
-
Ghermandi R, Pipola V, Terzi S, Tedesco G, Cavallari C, Bandiera S, Barbanti Bròdano G, Evangelisti G, Girolami M, and Gasbarrini A
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, COVID-19, Child, Female, Humans, Italy, Male, Middle Aged, Pandemics, Retrospective Studies, SARS-CoV-2, Young Adult, Betacoronavirus isolation & purification, Coronavirus Infections surgery, Coronavirus Infections virology, Neoplasms surgery, Neoplasms virology, Pneumonia, Viral surgery, Pneumonia, Viral virology, Spine surgery, Spine virology
- Abstract
Objective: Experience of Department of Oncologic and Degenerative Spine Surgery of Rizzoli Orthopaedic Institute during SARS-CoV-2 pandemic lockdown., Patients and Methods: Retrospective observational study of surgically treated patients from 09th March 2020 to 04th May 2020., Data Collected: age, sex, type of disease, neurological status, days of hospitalization, complications and type of discharge. A comparison analysis with same period of the last year was performed in order to evaluate the impact of COVID-19 spreading on daily surgical activity., Results: A total of 107 surgical procedures in 102 patients were performed from 09th March 2020 to 04th May 2020. Analysis showed a statistically significant difference in age, sex, ASIA class and type of treated disease compared to the same period of the last year (p=0.042, 0.006, 0.022 and 0.007, respectively). No statistically significant differences were observed in type of discharge, length of hospitalization and complications (p= 0.447, 0.261 and 0.127, respectively). 3 COVID-19 infections have been identified in hospitalized patients. 1 COVID-19 patient wad admitted from Emergency Department and was managed according to a dedicated path., Conclusions: Surgical activity was paradoxically increased during SARS-CoV-2 pandemic lockdown through the management of urgent and non-deferrable spinal disease with a low rate (3,9%) of COVID-19 infections.
- Published
- 2020
- Full Text
- View/download PDF